journal
Journals Handbook of Experimental Pharm...

Handbook of Experimental Pharmacology

https://read.qxmd.com/read/38554166/marine-natural-products-as-novel-treatments-for-parasitic-diseases
#1
JOURNAL ARTICLE
Wenbing Cheng, Yanbing Huang, Haijun Gao, Bolor Bold, Ting Zhang, Dengfeng Yang
Parasitic diseases including malaria, leishmaniasis, and trypanosomiasis have received significant attention due to their severe health implications, especially in developing countries. Marine natural products from a vast and diverse range of marine organisms such as sponges, corals, molluscs, and algae have been found to produce unique bioactive compounds that exhibit promising potent properties, including antiparasitic, anti-Plasmodial, anti-Leishmanial, and anti-Trypanosomal activities, providing hope for the development of effective treatments...
March 31, 2024: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/38509238/natural-products-derived-from-cannabis-sativa-for-pain-management
#2
JOURNAL ARTICLE
Erika Liktor-Busa, Tally M Largent-Milnes
Cannabis sativa is one of the oldest medicinal plants in human history. Even ancient physicians from hundreds of years ago used Cannabis sativa to treat several conditions like pain. In the modern era, the research community, including health-care providers, have witnessed wide-scale changes in cannabis policy, legislation, and marketing, with a parallel increase in patient interest. A simple search in PubMed using "cannabis and pain" as keywords provides more than 2,400 articles, about 80% of which were published in the last 8-10 years...
March 21, 2024: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/38421444/natural-products-and-diabetes-epicatechin-and-mechanisms-involved-in-the-regulation-of-insulin-sensitivity
#3
JOURNAL ARTICLE
Cesar G Fraga, Eleonora Cremonini, Monica Galleano, Patricia I Oteiza
Type 2 diabetes (T2D) is a disease that occurs when cells do not respond normally to insulin, a condition called insulin resistance, which leads to high blood glucose levels. Although it can be treated pharmacologically, dietary habits beyond carbohydrate restriction can be highly relevant in the management of T2D. Emerging evidence supports the possibility that natural products (NPs) could contribute to managing blood glucose or counteract the undesirable effects of hyperglycemia and insulin resistance. This chapter summarizes the relevant preclinical evidence involving the flavonoid (-)-epicatechin (EC) in the optimization of glucose homeostasis, reducing insulin resistance and/or diabetes-associated disorders...
March 1, 2024: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/38418669/natural-products-for-the-management-of-asthma-and-copd
#4
JOURNAL ARTICLE
Wupeng Liao, Quy T N Tran, Hong Yong Peh, Christabel Clare M Y Chan, W S Fred Wong
Chronic airway inflammatory diseases like asthma, chronic obstructive pulmonary disease (COPD), and their associated exacerbations cause significant socioeconomic burden. There are still major obstacles to effective therapy for controlling severe asthma and COPD progression. Advances in understanding the pathogenesis of the two diseases at the cellular and molecular levels are essential for the development of novel therapies. In recent years, significant efforts have been made to identify natural products as potential drug leads for treatment of human diseases and to investigate their efficacy, safety, and underlying mechanisms of action...
February 29, 2024: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/38418668/plant-derived-natural-products-for-the-treatment-of-bacterial-infections
#5
JOURNAL ARTICLE
Francisco Javier Álvarez-Martínez, Rocío Díaz-Puertas, Enrique Barrajón-Catalán, Vicente Micol
Bacterial infections are a significant public health concern, and the emergence of antibiotic-resistant bacteria (ARB) has become a major challenge for modern medicine. The overuse and misuse of antibiotics have contributed to the development of ARB, which has led to the need for alternative therapies. Plant-derived natural products (PNPs) have been extensively studied for their potential as alternative therapies for the treatment of bacterial infections. The diverse chemical compounds found in plants have shown significant antibacterial properties, making them a promising source of novel antibacterial agents...
February 29, 2024: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/38418667/natural-products-in-the-clinical-management-of-metabolic-syndrome
#6
JOURNAL ARTICLE
Ozra Tabatabaei-Malazy, Narges Lavari, Mohammad Abdollahi
Metabolic syndrome (MetS) is a prevalent health condition that requires significant attention and intervention due to its multifaceted nature. It encompasses a variety of ailments such as diabetes mellitus, hypertension, obesity, and dyslipidemia. Despite extensive research, the underlying pathophysiology of MetS is not entirely understood, and current synthetic drugs used to treat it have adverse effects and can be expensive. Therefore, natural products are being investigated as a potential alternative treatment for MetS...
February 29, 2024: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/38411727/natural-products-in-the-treatment-of-lower-urinary-tract-dysfunction-and-infection
#7
JOURNAL ARTICLE
Ann-Kathrin Lederer, Martin C Michel
The popularity of natural products for the treatment of lower urinary tract symptoms (LUTS) differs considerably between countries. Here we discuss the clinical evidence for efficacy in two indications, male LUTS suggestive of benign prostatic hyperplasia and urinary tract infections, and the mechanistic evidence from experimental studies. Most evidence for male LUTS is based on extracts from saw palmetto berries, stinging nettle roots, and pumpkin seeds, whereas most evidence for urinary tract infection is available for European golden rod and combined preparations although this field appears more fragmented with regard to extract sources...
February 28, 2024: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/38227198/signalling-of-adrenoceptors-canonical-pathways-and-new-paradigms
#8
JOURNAL ARTICLE
Chantel Mastos, Xiaomeng Xu, Alastair C Keen, Michelle L Halls
The concept of G protein-coupled receptors initially arose from studies of the β-adrenoceptor, adenylyl cyclase, and cAMP signalling pathway. Since then both canonical G protein-coupled receptor signalling pathways and emerging paradigms in receptor signalling have been defined by experiments focused on adrenoceptors. Here, we discuss the evidence for G protein coupling specificity of the nine adrenoceptor subtypes. We summarise the ability of each of the adrenoceptors to activate proximal signalling mediators including cAMP, calcium, mitogen-activated protein kinases, and protein kinase C pathways...
January 17, 2024: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/38177400/clinical-use-of-adrenergic-receptor-ligands-in-acute-care-settings
#9
JOURNAL ARTICLE
Erica Langnas, Mervyn Maze
In this chapter, we review how ligands, both agonists and antagonists, for the major classes of adrenoreceptors, are utilized in acute care clinical settings. Adrenergic ligands exert their effects by interacting with the three major classes of adrenoceptors. Adrenoceptor agonists and antagonists have important applications, ranging from treatment of hypotension to asthma, and have proven to be extremely useful in a variety of clinical settings of acute care from the operating room to the critical care environment...
January 5, 2024: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/38177399/targeted-molecular-therapeutics-for-pulmonary-diseases-addressing-the-need-for-precise-drug-delivery
#10
JOURNAL ARTICLE
Simone Carneiro, Joschka T Müller, Olivia M Merkel
Respiratory diseases are a major concern in public health, impacting a large population worldwide. Despite the availability of therapies that alleviate symptoms, selectively addressing the critical points of pathopathways remains a major challenge. Innovative formulations designed for reaching these targets within the airways, enhanced selectivity, and prolonged therapeutic effects offer promising solutions. To provide insights into the specific medical requirements of chronic respiratory diseases, the initial focus of this chapter is directed on lung physiology, emphasizing the significance of lung barriers...
January 5, 2024: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/38082203/adrenoceptors-in-the-eye-physiological-and-pathophysiological-relevance
#11
JOURNAL ARTICLE
Yue Ruan, Francesco Buonfiglio, Adrian Gericke
The autonomic nervous system plays a crucial role in the innervation of the eye. Consequently, it comes as no surprise that catecholamines and their corresponding receptors have been extensively studied and characterized in numerous ocular structures, including the cornea, conjunctiva, lacrimal gland, trabecular meshwork, uvea, and retina. These investigations have unveiled substantial clinical implications, particularly in the context of treating glaucoma, a progressive neurodegenerative disorder responsible for irreversible vision loss on a global scale...
December 12, 2023: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/37982890/%C3%AE-adrenoceptors-in-cancer-old-players-and-new-perspectives
#12
JOURNAL ARTICLE
Rosario Amato, Martina Lucchesi, Silvia Marracci, Luca Filippi, Massimo Dal Monte
Distress, or negative stress, is known to considerably increase the incidence of several diseases, including cancer. There is indeed evidence from pre-clinical models that distress causes a catecholaminergic overdrive that, mainly through the activation of β-adrenoceptors (β-ARs), results in cancer cell growth and cancer progression. In addition, clinical studies have evidenced a role of negative stress in cancer progression. Moreover, plenty of data demonstrates that β-blockers have positive effects in reducing the pro-tumorigenic activity of catecholamines, correlating with better outcomes in some type of cancers as evidenced by several clinical trials...
November 21, 2023: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/37973626/characterization-of-drug-delivery-systems-by-transmission-electron-microscopy
#13
JOURNAL ARTICLE
Stephanie Hoeppener
The contribution of electron microscopy, and here, in particular transmission electron microscopy (TEM), to the formulation and understanding of the biological action of drug delivery systems has led to a better insight into the design principles of drug delivery systems. TEM can be applied for particle characterization, for the visualization of the uptake and intracellular pathways of drug vehicles in cells and tissues and more recently can be also applied for the high-resolution investigation of drug-receptor interactions with near-atomic resolution...
November 17, 2023: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/37947907/slc26-anion-transporters
#14
JOURNAL ARTICLE
Eric R Geertsma, Dominik Oliver
Solute carrier family 26 (SLC26) is a family of functionally diverse anion transporters found in all kingdoms of life. Anions transported by SLC26 proteins include chloride, bicarbonate, and sulfate, but also small organic dicarboxylates such as fumarate and oxalate. The human genome encodes ten functional homologs, several of which are causally associated with severe human diseases, highlighting their physiological importance. Here, we review novel insights into the structure and function of SLC26 proteins and summarize the physiological relevance of human members...
November 11, 2023: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/37922034/new-therapeutic-options-in-pulmonal-diseases-sphingolipids-and-modulation-of-sphingolipid-metabolism
#15
JOURNAL ARTICLE
Burkhard Kleuser, Fabian Schumacher, Erich Gulbins
Sphingolipids are crucial molecules in the respiratory airways. As in most other tissues and organs, in the lung sphingolipids play an essential role as structural constituents as they regulate barrier function and fluidity of cell membranes. A lung-specific feature is the occurrence of sphingolipids as minor structural components in the surfactant. However, sphingolipids are also key signaling molecules involved in airway cell signaling and their dynamical formation and metabolism are important for normal lung physiology...
November 4, 2023: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/37861719/looking-to-the-future-drug-delivery-and-targeting-in-the-prophylaxis-and-therapy-of-severe-and-chronic-diseases
#16
JOURNAL ARTICLE
Monika Schäfer-Korting
High molecular weight actives and cell-based therapy have the potential to revolutionize the prophylaxis and therapy of severe diseases. Yet, the size and nature of the agents - proteins, nucleic acids, cells - challenge drug delivery and thus formulation development. Moreover, off-target effects may result in severe adverse drug reactions. This makes delivery and targeting an essential component of high-end drug development. Loading to nanoparticles facilitates delivery and enables targeted mRNA vaccines and tumor therapeutics...
October 21, 2023: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/37815594/using-human-ipsc-derived-peripheral-nervous-system-disease-models-for-drug-discovery
#17
JOURNAL ARTICLE
Yuan Gao
Induced pluripotent stem cells (IPSCs), with their remarkable ability to differentiate into various cell types, including peripheral nervous system cells such as neurons and glial cells, offer an excellent platform for in vitro disease modeling. These iPSC-derived disease models have proven valuable in drug discovery, as they provide more precise simulations of a patient's disease state and allow for the assessment of potential therapeutic effectiveness and safety.
October 11, 2023: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/37735301/applications-of-induced-pluripotent-stem-cell-derived-glia-in-brain-disease-research-and-treatment
#18
JOURNAL ARTICLE
Zhiqi Yang, Mingyue Gong, Chuanyan Yang, Chunhai Chen, Kuan Zhang
Glia are integral components of neural networks and are crucial in both physiological functions and pathological processes of the brain. Many brain diseases involve glial abnormalities, including inflammatory changes, mitochondrial damage, calcium signaling disturbance, hemichannel opening, and loss of glutamate transporters. Induced pluripotent stem cell (iPSC)-derived glia provide opportunities to study the contributions of glia in human brain diseases. These cells have been used for human disease modeling as well as generating new therapies...
September 22, 2023: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/37733107/advanced-formulation-approaches-for-emerging-therapeutic-technologies
#19
JOURNAL ARTICLE
Nour Allahham, Ines Colic, Melissa L D Rayner, Pratik Gurnani, James B Phillips, Ahad A Rahim, Gareth R Williams
In addition to proteins, discussed in the Chapter "Advances in Vaccine Adjuvants: Nanomaterials and Small Molecules", there are a wide range of alternatives to small molecule active ingredients. Cells, extracellular vesicles, and nucleic acids in particular have attracted increasing research attention in recent years. There are now a number of products on the market based on these emerging technologies, the most famous of which are the mRNA-based vaccines against SARS-COV-2. These advanced therapeutic moieties are challenging to formulate however, and there remain significant challenges for their more widespread use...
September 22, 2023: Handbook of Experimental Pharmacology
https://read.qxmd.com/read/37709918/asthma-and-copd-a-focus-on-%C3%AE-agonists-past-present-and-future
#20
JOURNAL ARTICLE
Jillian G Baker, Dominick E Shaw
Asthma has been recognised as a respiratory disorder for millennia and the focus of targeted drug development for the last 120 years. Asthma is one of the most common chronic non-communicable diseases worldwide. Chronic obstructive pulmonary disease (COPD), a leading cause of morbidity and mortality worldwide, is caused by exposure to tobacco smoke and other noxious particles and exerts a substantial economic and social burden. This chapter reviews the development of the treatments of asthma and COPD particularly focussing on the β-agonists, from the isolation of adrenaline, through the development of generations of short- and long-acting β-agonists...
September 15, 2023: Handbook of Experimental Pharmacology
journal
journal
27574
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.